Delivery Order SPE2DB20D2104-SPE2DB25FMYVQ
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 14, 2025, for Cetirizine HCL 10 mg tablets (100-count) with a ceiling value of $1,088.45. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Cetirizine HCL 5 mg tablets (100-count packages) with a ceiling value of $5,565.77. This is a firm fixed-price delivery order executed under a non-set-aside competitive procurement, with an ultimate completion date of December 17, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Cetirizine HCL 5 mg tablets (100-count packages) with a ceiling value of $7,861.18. This firm fixed price delivery order, with an ultimate completion date of September 17, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract was awarded on a competitive basis with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,073.98 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets in quantities of 300 units. The contract was competitively awarded without set-aside designation and is classified as a firm fixed-price delivery order with an ultimate completion date of November 21, 2025. This award was issued on November 20, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,284.65 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100-count packages) on July 14, 2025, with completion targeted for July 15, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and represents a continuation of the contractor's role as a critical pharmaceutical supplier to federal healthcare systems. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cetirizine HCL 5 mg tablets (100-count) with a contract value of $4,896.02 and an ultimate completion date of October 31, 2025. This is a firm fixed-price delivery order issued without set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cetirizine HCL 5 mg tablets (100-count units) on September 10, 2025, with a ceiling value of $4,911.62 and ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,194.41 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets (300 count) on November 10, 2025, with completion scheduled for November 12, 2025. This competitively awarded, firm fixed-price delivery order includes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Cetirizine HCL 10 mg tablets in quantities of 500 units. This firm fixed-price delivery order, valued at $2,119.84, represents a non-competitive set-aside award and carries a completion deadline of August 22, 2025. The pharmaceutical products will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Cetirizine HCL 10 mg tablets (300 count) with a ceiling value of $1,073.98. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from competitive procurement. The contract is scheduled for ultimate completion by November 18, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYVQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for cetirizine HCL 5 mg tablets (100-count) with a ceiling value of $2,819.59 under a firm fixed price contract type. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-competitive set-aside delivery against AmerisourceBergen's larger contract vehicle. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. This prime vendor contract serves as the primary pharmaceutical supply vehicle for the Defense Health Agency and military healthcare systems, enabling the company to fulfill critical medication requirements across multiple therapeutic domains. The IDC structure allows AmerisourceBergen to respond efficiently to federal medical procurement needs while the DLA prepares for next-generation Pharmaceutical Prime Vendor Global Program contracts anticipated to involve multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/26/25 |